InvestorsHub Logo

Amigo Mike

04/27/17 12:36 PM

#26483 RE: wimuskyfisherman #26479

wimusky,


Amigo- I looked back at some of your posts. Last year you were of the opinion that the ANDAs had some value. You were even talking about partnering/commercialization of them adding value to the company. We are about to achieve that with Seroquel, the additional Focalin strengths and Pristiq and Lamictal have been partnered. So I would personally argue these developments should add value to the company. In your recent posts, I am under the impression that you find no value in Seroquel and the other ANDAs and only see value in Rexista and PODRAS. I am wondering why your opinions have changed in regards to this.



Your impressions are not correct. Not going to explain any more.

Amigo Mike